Chun Chao to Child
This is a "connection" page, showing publications Chun Chao has written about Child.
Connection Strength
0.898
-
Discussions About Goals of Care and Advance Care Planning Among Adolescents and Young Adults With Cancer Approaching the End of Life. J Clin Oncol. 2023 10 20; 41(30):4739-4746.
Score: 0.137
-
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
Score: 0.129
-
Long-term Health Outcomes in Survivors of Childhood Cancer Diagnosed Between 1990 and 2000 in a Large US Integrated Health Care System. J Pediatr Hematol Oncol. 2016 Mar; 38(2):123-30.
Score: 0.081
-
A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health. 2015 Jan; 56(1):85-90.
Score: 0.074
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
Score: 0.060
-
Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010 Feb 01; 171(3):357-67.
Score: 0.053
-
Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc. 2009 Oct; 84(10):864-70.
Score: 0.052
-
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009 Jun; 99(6):1137-42.
Score: 0.051
-
Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024 Jan 04; 8(1).
Score: 0.035
-
Patient, Family, and Clinician Perspectives on Location of Death for Adolescents and Young Adults With Cancer. JCO Oncol Pract. 2022 10; 18(10):e1621-e1629.
Score: 0.032
-
An imputation method for calculating and comparing autoimmune disease incidence using partial case review. Vaccine. 2017 12 04; 35(48 Pt B):6672-6675.
Score: 0.023
-
Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017 02 07; 35(6):897-902.
Score: 0.022
-
Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013. Am J Public Health. 2015 Dec; 105(12):2549-56.
Score: 0.020
-
Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example. Vaccine. 2015 Nov 17; 33(46):6224-6.
Score: 0.020
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.019
-
Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
Score: 0.016
-
Correlates for second-dose varicella vaccination in school-age children in a managed care organization in California. Pediatr Infect Dis J. 2012 Jul; 31(7):752-5.
Score: 0.016
-
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine. 2012 Jun 29; 30(31):4585-7.
Score: 0.016
-
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012; 16(3):37-41.
Score: 0.015
-
Second-dose varicella vaccination coverage in children and adolescents in a managed care organization in California, 2006-2009. Pediatr Infect Dis J. 2011 Aug; 30(8):705-7.
Score: 0.015
-
Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Pediatr Infect Dis J. 2010 Mar; 29(3):205-8.
Score: 0.013